Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 6
2004 1
2005 4
2006 2
2007 1
2008 1
2009 1
2010 2
2011 3
2012 1
2013 2
2014 4
2015 3
2016 3
2017 3
2018 2
2019 2
2020 6
2021 4
2022 6
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
Neutrophil to lymphocyte ratio (NTLR) predicts local control and overall survival after stereotactic body radiotherapy (SBRT) in metastatic sarcoma.
Somasundaram E, Anderson PM, Smile TD, Halima A, Broughman JB, Reddy CA, Parsai S, Scott JG, Chan T, Campbell S, Angelov L, Zahler S, Trucco M, Thomas SM, Johnson S, Qi P, Magnelli A, Murphy ES. Somasundaram E, et al. Among authors: anderson pm. Sci Rep. 2023 Nov 7;13(1):19256. doi: 10.1038/s41598-023-46476-3. Sci Rep. 2023. PMID: 37935813 Free PMC article.
Salvage stereotactic body radiation therapy re-irradiation for unresectable locally recurrent nasopharyngeal rhabdomyosarcoma in a young adult: A case report.
Buchberger DS, Cook SK, Anderson PM, Shepard DR, Ku JA, Fritz MA, Sindwani R, Recinos P, Murphy ES, Koyfman SA. Buchberger DS, et al. Among authors: anderson pm. Pediatr Blood Cancer. 2023 Oct;70(10):e30548. doi: 10.1002/pbc.30548. Epub 2023 Jul 17. Pediatr Blood Cancer. 2023. PMID: 37461101 No abstract available.
Neutrophil to Lymphocyte Ratio (NTLR) Predicts Local Control Failure and Overall Survival after Stereotactic Body Radiotherapy (SBRT) In Metastatic Sarcoma.
Somasundaram E, Smile TD, Halima A, Broughman JB, Reddy CA, Parsai S, Scott JG, Chan T, Campbell S, Angelov L, Zahler S, Trucco M, Thomas SM, Johnson S, Qi P, Magnelli A, Anderson PM, Murphy ES. Somasundaram E, et al. Among authors: anderson pm. Res Sq [Preprint]. 2023 Jun 8:rs.3.rs-2570832. doi: 10.21203/rs.3.rs-2570832/v1. Res Sq. 2023. PMID: 37333401 Free PMC article. Updated. Preprint.
Tilsotolimod Exploits the TLR9 Pathway to Promote Antigen Presentation and Type 1 IFN Signaling in Solid Tumors: A Multicenter International Phase I/II Trial (ILLUMINATE-101).
Babiker H, Borazanci E, Subbiah V, Agarwala S, Algazi A, Schachter J, Lotem M, Maurice-Dror C, Hendler D, Rahimian S, Minderman H, Haymaker C, Mahadevan D, Bernatchez C, Murthy R, Hultsch R, Kaplan N, Woodhead G, Hennemeyer C, Chunduru S, Anderson PM, Diab A, Puzanov I. Babiker H, et al. Among authors: anderson pm. Clin Cancer Res. 2022 Dec 1;28(23):5079-5087. doi: 10.1158/1078-0432.CCR-21-4486. Clin Cancer Res. 2022. PMID: 35917516
Association between biologically effective dose and local control after stereotactic body radiotherapy for metastatic sarcoma.
Somasundaram E, D Smile T, Halima A, Broughman JB, Reddy CA, Parsai S, Scott JG, Shah C, Chan T, Campbell S, Angelov L, Anderson PM, Zahler S, Trucco M, Thomas SM, Johnson S, Mesko N, Nystrom L, Shepard D, Budd GT, Qi P, Magnelli A, Murphy ES. Somasundaram E, et al. Among authors: anderson pm. J Radiosurg SBRT. 2022;8(4):265-273. J Radiosurg SBRT. 2022. PMID: 37416333 Free PMC article.
55 results